The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
Contact phone
Sparrow Clinical Research Institute | 517.364.5760
Contact email
scri@sparrow.org
Principal investigator
Dr. Nam Cho, DO
Trial Category
Heart & Vascular
Trial SubCategory
Atrial Fibrillation
Webform